Pfizer, Moderna, and Johnson & Johnson are expected to increase the amount of COVID-19 vaccines in the United States to a total of 240 million doses by the end of March. This amount would be able to vaccinate about 130 million people. Pfizer is to produce more than 13 million doses of its two-shot vaccine by mid-March. John Young, Chief Business Officer, explained that Pfizer is on its path to release 120 million doses by the end of March and 80 million doses by the end of May. Moderna is expected to double its vaccine shipments by April, which contains 40 million doses distributed per month. Johnson & Johnson aims to distribute more than 20 million doses of their one-shot vaccine by the end of March, and they are confident that they can provide 100 million doses during the first half of 2021.